The Impact of Social Media-delivered Chemotherapy Side Effects Education for Breast Cancer Patients Receiving Chemotherapy

NCT06791603 | Recruiting

• 1 other identifier: TMU-JIRB N202410024
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to learn if a standardized pharmacists-provided education module by social media can improve patients' knowledge of chemotherapy-related side effects. The main questions it aims to answer is:

• Do patients who received a standardized pharmacists-provided education module by social media improve their knowledge of chemotherapy-related side effects? Researchers will compare standardized chemotherapy education +video (experimental group) versus chemotherapy handouts (control group). Participants will:
• Received standardized chemotherapy education + video or chemotherapy handouts at the first and second chemotherapy section.
• Fill out a questionnaire for outcomes assessment.

Conditions

Chemotherapy Side Effects; Social Media; Education of Patients

Keywords

pharmacist; chemotherapy education; social media

Outcome Measures

Primary Outcomes (1)

• A questionnaire with 5 questions of side effects management

  Each question is a multiple choice with 4 options and 1 correct answer

  1. First time receiving chemotherapy 2. Second time receiving chemotherapy (3 to 4 weeks depend on schedule)

Secondary Outcomes (1)

• FACT-B, The Functional Assessment of Cancer Therapy - Breast

  1. First time receiving chemotherapy 2. Second time receiving chemotherapy (3 to 4 weeks depend on schedule)

Study Arms (2)

Standardized chemotherapy education + video

EXPERIMENTAL

Standardized chemotherapy education+ video

Other: Standardized chemotherapy education + video

Chemotherapy handouts

NO INTERVENTION

Chemotherapy handouts

Interventions

Standardized chemotherapy education + video OTHER

Videos will be provided with patients and they will watch videos during the visit. The information regarding the prevention and management of side effects and further instructions when to visit hospital. Patients will have access to videos and watch videos after leaving the hospital for the entire treatment course

Standardized chemotherapy education + video

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Breast cancer patients aged 18 or older undergoing their first chemotherapy.
• Possess a smartphone and are able to watch videos on it.

You may not qualify if:

• Unable to read or complete questionnaires in Chinese.
• Cognitive impairments.
• Pregnant women.

Sponsors & Collaborators

• Taipei Medical University Shuang Ho Hospital: lead

Study Sites (1)

Shuang Ho Hospital

New Taipei City, Taiwan

RECRUITING

MeSH Terms

Interventions

Videotape Recording

Intervention Hierarchy (Ancestors)

Tape Recording; Audiovisual Aids; Educational Technology; Technology; Technology, Industry, and Agriculture; Television

Study Officials

• Pohung Lin, PharmD

  Taipei Medical University Shuang Ho Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Pohung Lin, PharmD

CONTACT

886-933-826-267; 19365@s.tmu.edu.tw

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator, clinical pharmacist

Study Record Dates

• First Submitted: January 11, 2025
• First Posted: January 24, 2025
• Study Start: January 6, 2025
• Primary Completion: December 31, 2025
• Study Completion: January 31, 2026
• Last Updated: January 24, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)